Are Atrial High-Rate Episodes Associated With Increased Risk of Ventricular Arrhythmias and Mortality?

[1]  A. Capucci,et al.  Does the CHA2DS2-VASc score reliably predict atrial arrhythmias? Analysis of a nationwide database of remote monitoring data transmitted daily from cardiac implantable electronic devices. , 2018, Heart rhythm.

[2]  Rajiv Mahajan,et al.  Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis , 2018, European heart journal.

[3]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association , 2018, Circulation.

[4]  L. Jordaens,et al.  Catheter Ablation for Atrial Fibrillation with Heart Failure , 2018, The New England journal of medicine.

[5]  Panos Vardas,et al.  Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial , 2017, American heart journal.

[6]  Peng-Sheng Chen,et al.  Skin sympathetic nerve activity precedes the onset and termination of paroxysmal atrial tachycardia and fibrillation. , 2017, Heart rhythm.

[7]  Philippe Mabo,et al.  Rationale and design of the Apixaban for the Reduction of Thrombo‐Embolism in Patients With Device‐Detected Sub‐Clinical Atrial Fibrillation (ARTESiA) trial , 2017, American heart journal.

[8]  A. Capucci,et al.  Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT , 2017, European heart journal.

[9]  Segyeong Joo,et al.  Prediction of Ventricular Tachycardia One Hour before Occurrence Using Artificial Neural Networks , 2016, Scientific Reports.

[10]  John L Sapp,et al.  Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. , 2016, The New England journal of medicine.

[11]  Dhanunjaya R. Lakkireddy,et al.  Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial , 2016, Circulation.

[12]  Andrea Mazzanti,et al.  2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.

[13]  W. Stevenson,et al.  Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. , 2015, Heart rhythm.

[14]  Renato Pietro Ricci,et al.  HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. , 2015, Heart rhythm.

[15]  G. Hindricks,et al.  Impact of single atrial fibrillation catheter ablation on implantable cardioverter defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  B. Gorenek,et al.  The onset mechanisms of ventricular tachycardia. , 2013, International journal of cardiology.

[17]  R. Verlato,et al.  Clinical Characteristics, Mortality, Cardiac Hospitalization, and Ventricular Arrhythmias in Patients Undergoing CRT‐D Implantation: Results of the ACTION‐HF Study , 2013, Journal of cardiovascular electrophysiology.

[18]  Tommy Andersson,et al.  All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case–control study , 2013, European heart journal.

[19]  Jeroen J. Bax,et al.  Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy. , 2009, Heart rhythm.

[20]  T. Bunch,et al.  Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality. , 2009, Heart rhythm.

[21]  J. Seward,et al.  Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. , 2007, Journal of the American College of Cardiology.

[22]  P. Hildebrandt,et al.  Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction , 2007, European journal of heart failure.

[23]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[24]  J. Murabito,et al.  Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality The Framingham Heart Study , 2003, Circulation.

[25]  Suneet Mittal,et al.  Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients? , 2002, Journal of the American College of Cardiology.

[26]  A. Workman,et al.  The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. , 2001, Cardiovascular research.

[27]  S. Hohnloser,et al.  Association Between Atrial Fibrillation and Appropriate Implantable Cardioverter Defibrillator Therapy:Results from a Prospective Study , 2000, Journal of cardiovascular electrophysiology.

[28]  M A Waclawiw,et al.  Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. , 1998, Journal of the American College of Cardiology.

[29]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[30]  B. Lerman.  Mechanoelectrical Feedback: Maturation of a Concept , 1996, Journal of cardiovascular electrophysiology.

[31]  M. Akhtar,et al.  Facilitation of macroreentry within the His-Purkinje system with abrupt changes in cycle length. , 1984, Circulation.

[32]  B Lown,et al.  Neural activity and ventricular fibrillation. , 1976, The New England journal of medicine.